Q/ How does the AMCA compare with its competitors?
A/ The AMCA (Advanced Medium Combat Aircraft) is not a copy of any aircraft. It was designed to match the Indian Air Force’s requirements. It is a fifth-generation fighter and one of the few in that category. It will not be right to compare it with any other aircraft. For example, the F-35 is much bigger and heavier. But, the AMCA’s technology and capabilities will be at par with any other fifth-generation fighter in the world.
Q/ What lessons did you learn from the Tejas project?
A/ Tejas is not just a programme, but the development of a complete ecosystem. It has been a learning exercise because it was our first venture into 4.5-generation combat aircraft. In Tejas, all core technologies were developed indigenously. We have realised that we need to involve all stakeholders right from the beginning. During the development of Tejas, we were focused on proving the technologies and flying capability, and ignored the maintenance part. Flyers and ground staff are equally important. Ground support equipment like trolleys and weapon-loading platforms have to be factored in at the design phase. It cannot happen at the end. In the AMCA, even before the aircraft is ready, all these areas have been addressed and are on track.
Q/ The AMCA is projected as a fighter for the next 30 years of war. Why?
A/ It is designed for future upgrades as its architecture allows it to incorporate new systems easily. Its basic airframe is stealth- and future-friendly. Avionics, sensors and radars can be upgraded when required. Normally, the shelf life of an aircraft is 30 years, and the AMCA is designed to take care of upgrades for that period.
This story is from the May 01, 2022 edition of THE WEEK.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the May 01, 2022 edition of THE WEEK.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
WHAT IS YOUR SLEEP PATTERN?
YOUR SLEEP PATTERN may influence your risk of chronic diseases.
VISION PROBLEMS MAY BE AN EARLY SIGN OF ALZHEIMER'S
ACCORDING TO A US STUDY published in The Lancet Neurology, a rare eye condition known as posterior cortical atrophy (PCA) could be the first symptom of Alzheimer’s disease in 10 per cent of patients.
ANNUAL BREAST CANCER SCREENING BEGINNING AT 40 SAVES LIVES
ANNUAL MAMMOGRAMS to screen for breast cancer beginning at age 40 and continuing to at least 79 has the highest reduction in mortality with minimal risks, according to a US study published in the journal Radiology.
SWEETENED DRINKS MAY INCREASE RISK OF AFib
REGULARLY CONSUMING SUGARY or artificially sweetened beverages can increase the risk of developing atrial fibrillation, the most common type of heart arrhythmia or irregular heartbeat.
MOST EFFECTIVE EXERCISES TO TREAT DEPRESSION
A STUDY PUBLISHED IN THE BMJ says walking, jogging, yoga, strength training and dancing are the most effective exercises to treat depression, especially when intense.
LYING TO YOUR KIDS MAY MAKE THEM LIARS
KIDS WHOSE PARENTS LIE to them are more likely to lie to their parents, even if parents tell only innocent white lies, according to a study published in the Journal of Experimental Child Psychology.
BAD AIR DAZE
AIR POLLUTION'S EFFECTS GO BEYOND THE LUNGS, IMPACTING FERTILITY AND MENTAL HEALTH, BESIDES YOUR EYES AND SKIN
Women and the big C
Cancer is one of the leading causes of death in India. Here, we bust common myths, and outline diagnosis, treatment and prevention strategies
Make genome the norm
For India to meet its target of TB eradication by 2025, it will have to make rapid strides in using whole genome sequencing to its full potential
ULTRA-PROCESSED FOOD LINKED TO 32 MAJOR HEALTH ISSUES
Regular consumption of ultra-processed food is associated with an increased risk of 32 major health outcomes, including early death, cancer, mental health disorders, obesity, type 2 diabetes and respiratory, cardiovascular and gastrointestinal diseases.